CEND1

CEND1 (BM88) is a neuron-enriched integral membrane protein that couples cell cycle exit with differentiation by coordinating mitochondrial energy metabolism and cell cycle regulatory pathways. It enforces G0/G1 arrest through the p53/cyclin D1/pRb axis and suppression of Notch1 signaling, acting downstream of the proneural transcription factors Mash1 and Neurog2 to commit precursors to a neuronal fate (PMID:16893893, PMID:17971443, PMID:26321141). At the mitochondrial membrane, CEND1 forms GXXXA-motif-dependent homodimers that interact with ATP synthase subunit Atp5f1b to enhance ATP production, while its degradation is promoted by CDK5/p25-mediated phosphorylation; loss of CEND1 increases Drp1-dependent mitochondrial fission, impairs respiratory chain activity, and exacerbates ischemia-reperfusion injury (PMID:35732922, PMID:41469760). Beyond the nervous system, LSD1-dependent H3K4 demethylation at the Cend1 promoter suppresses its transcription to permit cardiomyocyte proliferation, and genetic deletion of Cend1 rescues embryonic lethality of Lsd1-null hearts and promotes cardiac regeneration after injury (PMID:38226173, PMID:40521201).

1. 1995 High

   Establishing CEND1 as a neuron-specific integral membrane protein capable of driving neuronal differentiation resolved its basic identity and suggested a functional role in neuronal commitment.

   Evidence Biochemical purification, EM immunocytochemistry of rat brain, and gain-of-function in Neuro-2a cells showing accelerated neurite outgrowth and neurofilament expression

   PMID:7616611 PMID:7775480

   Open questions at the time

   • Mechanism by which membrane localization relates to differentiation unknown
   • Downstream signaling pathway not identified
   • No loss-of-function data yet
2. 2006 High

   Demonstrating that CEND1 enforces G0/G1 arrest through p53 upregulation, pRb hypophosphorylation, and cyclin D1 downregulation/relocalization identified the cell cycle machinery through which it operates.

   Evidence FACS, BrdU, and Western blot with both overexpression and siRNA knockdown in Neuro-2a cells

   PMID:16893893

   Open questions at the time

   • Direct biochemical target of CEND1 in the p53/cyclin D1/pRb cascade not identified
   • Whether effects are cell-autonomous in vivo unknown
3. 2007 High

   Positioning CEND1 downstream of Mash1 and upstream of Notch1 suppression in spinal cord neural progenitors established its place in the proneural gene hierarchy that links cell cycle exit to neuronal fate commitment.

   Evidence Gain-of-function electroporation and siRNA knockdown in spinal cord neural precursors with Mash1/Notch1 expression analysis

   PMID:17971443

   Open questions at the time

   • Whether CEND1 directly modulates Notch1 or acts indirectly through cell cycle exit unclear
   • Upstream regulation of CEND1 transcription beyond Mash1 not defined
4. 2008 Medium

   Linking CEND1 to suppression of IP3-sensitive ER calcium release and ceramide-induced apoptosis expanded its mechanism beyond transcriptional cell cycle control to calcium-dependent signaling, while identification as a mediator of HDAC inhibitor effects revealed its epigenetic regulation.

   Evidence Calcium imaging in CEND1-overexpressing Neuro-2a and HeLa cells; TSA treatment with Cend1 siRNA rescue in neuroblastoma cells

   PMID:18258204 PMID:19061903

   Open questions at the time

   • Direct target in calcium signaling pathway not identified
   • Whether calcium effects are upstream or parallel to cell cycle arrest unknown
   • HDAC inhibitor mechanism is indirect — specific histone marks not mapped
5. 2010 High

   The Cend1 knockout mouse demonstrated that CEND1 is required in vivo for cell cycle exit, migration, and differentiation of cerebellar granule cell precursors, providing genetic validation of the overexpression studies.

   Evidence Cend1 KO mouse with BrdU incorporation, immunohistochemistry, and motor behavior tests

   PMID:20153830

   Open questions at the time

   • Molecular mechanism of migration defect not resolved
   • Whether cerebellar phenotype reflects cell-autonomous function not formally shown
6. 2013 Medium

   Identification of RanBPM and Dyrk1B as CEND1 binding partners forming a tripartite complex that regulates cyclin D1 stability, and of Ahi1 as a stabilizer of CEND1 that mediates hypothalamic neurite extension, defined the protein interaction landscape.

   Evidence Co-immunoprecipitation and co-expression studies in Neuro-2a cells (RanBPM/Dyrk1B); mass spectrometry of Ahi1 immunoprecipitates, Ahi1 KO mice, and CEND1 rescue of neurite defects

   PMID:23658157 PMID:24312406

   Open questions at the time

   • Direct binding interfaces between CEND1, RanBPM, and Dyrk1B not mapped
   • Stoichiometry and in vivo relevance of the tripartite complex not established
   • How Ahi1 stabilizes CEND1 protein mechanistically is unknown
7. 2019 High

   Extending the Cend1 KO analysis to forebrain interneurons revealed that CEND1 is required for GABAergic interneuron generation from the MGE and adult hippocampal neurogenesis, linking it to anxiety and cognitive phenotypes.

   Evidence Cend1 KO mouse with proliferation/apoptosis assays in MGE, interneuron quantification, and behavioral testing (EPM, fear conditioning, Morris water maze)

   PMID:30760981

   Open questions at the time

   • Whether interneuron deficit is cell-autonomous or secondary to niche effects unclear
   • Specific Cend1-dependent transcriptional program in MGE progenitors not defined
8. 2021 Medium

   Demonstrating that Arhgef2 promotes Mettl14-dependent m6A methylation of Cend1 mRNA to enable its nuclear export and translation revealed a post-transcriptional regulatory layer controlling CEND1 protein levels during neurogenesis.

   Evidence m6A sequencing, Arhgef2 KO mice, mRNA nuclear export assay, and Cend1 overexpression rescue of neurogenesis defects

   PMID:34142067

   Open questions at the time

   • Specific m6A reader mediating Cend1 mRNA export not identified
   • Whether m6A regulation operates in adult neurogenesis unknown
9. 2022 High

   Localizing CEND1 to presynaptic mitochondria and showing that CDK5/p25 phosphorylates and degrades CEND1 — leading to Drp1-dependent mitochondrial fission and cognitive decline in Alzheimer's disease models — established CEND1 as a mitochondrial homeostasis factor with disease relevance.

   Evidence Subcellular fractionation, Co-IP of CDK5/p25-CEND1, phosphorylation assays, Cend1 KO mice, AAV-CEND1 rescue of cognitive deficits in 5xFAD mice

   PMID:35732922

   Open questions at the time

   • Phosphorylation site(s) on CEND1 not mapped
   • Mechanism linking CEND1 to Drp1 regulation not defined
   • Whether mitochondrial and cell cycle functions are separable unknown
10. 2023 High

    Identifying LSD1-mediated H3K4me2 demethylation at the Cend1 promoter as the epigenetic switch controlling cardiomyocyte proliferation — validated by genetic epistasis where Cend1 deletion rescues Lsd1-null embryonic lethality — extended CEND1 function beyond the nervous system.

    Evidence Cardiomyocyte-specific Lsd1 KO, Cend1 KO, ChIP for H3K4me2, RNA-seq, double-KO rescue of embryonic lethality

    PMID:38226173

    Open questions at the time

    • Whether CEND1 operates through the same p53/cyclin D1 axis in cardiomyocytes as in neurons not tested
    • Cardiac-specific CEND1 interactors not identified
11. 2025 High

    Resolving the structural basis of CEND1 mitochondrial function — GXXXA-motif homodimers that interact with Atp5f1b to enhance ATP synthase activity — and demonstrating that dimerization-defective mutants are rapidly degraded, provided a reconstitution-level mechanism for its bioenergetic role.

    Evidence Site-directed mutagenesis (G130P), Co-IP of CEND1-Atp5f1b, mitochondrial membrane potential/ATP/mPTP/Complex I/V assays, Cend1 KO ischemia-reperfusion model

    PMID:41469760

    Open questions at the time

    • Structural model of the CEND1-Atp5f1b interface not available
    • Whether dimerization is required for cell cycle exit function unknown
12. 2025 Medium

    Showing that CEND1 activates AMPK, inhibits PDH and oxidative phosphorylation in glioma cells, and enhances metformin sensitivity linked its anti-proliferative and metabolic functions in a cancer context, though the direction of ATP effects appears context-dependent relative to the Atp5f1b interaction.

    Evidence CEND1 overexpression in glioma cell lines and orthotopic models with metabolomics, PDH activity, mitochondrial respiration, and ATP assays

    PMID:41239369

    Open questions at the time

    • Apparent contradiction with ATP-enhancing role via Atp5f1b not reconciled
    • Whether AMPK activation is direct or secondary to metabolic changes unknown
    • Relevance to normal neuronal physiology unclear
13. 2025 High

    Extending the LSD1-CEND1 axis to cardiac regeneration showed that Cend1 deletion or Lsd1 overexpression promotes neonatal and adult heart repair after injury, establishing therapeutic relevance of CEND1 suppression in cardiac disease.

    Evidence Cardiomyocyte-specific KO/overexpression mice, apical resection, LAD ligation, echocardiography, RNA-seq

    PMID:40521201

    Open questions at the time

    • Downstream effectors of CEND1 in cardiomyocyte cell cycle re-entry not defined
    • Long-term safety of Cend1 suppression in the heart not assessed

• Key unresolved questions include: how the mitochondrial (Atp5f1b/ATP synthesis) and cell cycle (p53/cyclin D1/pRb) functions of CEND1 are mechanistically integrated, what its direct biochemical activity is, whether its apparently opposite effects on ATP in neurons versus glioma reflect context-dependent interactions, and what the structural basis of its homodimer and Atp5f1b interaction is.
• No structural data for CEND1 or its complexes
• Direct enzymatic or scaffolding activity not established
• Reconciliation of ATP-enhancing and ATP-suppressing phenotypes needed
• Phosphorylation sites and their functional significance not mapped